Drug Profile
Research programme: hexosaminidase-C-inhibitors - Lallemand Aquapharm/University of Dundee
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Aquapharm Biodiscovery; University of Dundee
- Developer Lallemand Aquapharm; University of Dundee
- Class
- Mechanism of Action Hexosaminidase C inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Alzheimer's-disease in United Kingdom
- 20 Sep 2010 Early research in Alzheimer's disease in United Kingdom (unspecified route)